AP2888A - Injectable preparations of diclofenic and its pharmaceutically acceptable salts - Google Patents

Injectable preparations of diclofenic and its pharmaceutically acceptable salts

Info

Publication number
AP2888A
AP2888A AP2007004101A AP2007004101A AP2888A AP 2888 A AP2888 A AP 2888A AP 2007004101 A AP2007004101 A AP 2007004101A AP 2007004101 A AP2007004101 A AP 2007004101A AP 2888 A AP2888 A AP 2888A
Authority
AP
ARIPO
Prior art keywords
diclofenic
pharmaceutically acceptable
acceptable salts
injectable preparations
injectable
Prior art date
Application number
AP2007004101A
Other languages
English (en)
Other versions
AP2007004101A0 (en
Inventor
Rajnibhai Ketan Patel
Milan Rajnibhai Patel
Original Assignee
Troikaa Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36953757&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2888(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Troikaa Pharmaceuticals Ltd filed Critical Troikaa Pharmaceuticals Ltd
Publication of AP2007004101A0 publication Critical patent/AP2007004101A0/xx
Application granted granted Critical
Publication of AP2888A publication Critical patent/AP2888A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
AP2007004101A 2005-02-01 2006-01-30 Injectable preparations of diclofenic and its pharmaceutically acceptable salts AP2888A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN96MU2005 2005-02-01
PCT/IN2006/000033 WO2006095363A2 (en) 2005-02-01 2006-01-30 Injectable preparations of diclofenic and its pharmaceutically acceptable salts

Publications (2)

Publication Number Publication Date
AP2007004101A0 AP2007004101A0 (en) 2007-08-31
AP2888A true AP2888A (en) 2014-05-31

Family

ID=36953757

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2007004101A AP2888A (en) 2005-02-01 2006-01-30 Injectable preparations of diclofenic and its pharmaceutically acceptable salts

Country Status (20)

Country Link
US (1) US8809393B2 (xx)
EP (1) EP1848419B1 (xx)
JP (1) JP2008528572A (xx)
KR (1) KR101226121B1 (xx)
CN (1) CN101123957B (xx)
AP (1) AP2888A (xx)
AU (2) AU2006221633B2 (xx)
BR (1) BRPI0606119B8 (xx)
CA (1) CA2596031C (xx)
DK (1) DK1848419T3 (xx)
EA (1) EA013616B1 (xx)
ES (1) ES2392097T3 (xx)
IL (1) IL184697A (xx)
MX (1) MX2007009312A (xx)
NZ (1) NZ554779A (xx)
PL (1) PL1848419T3 (xx)
PT (1) PT1848419E (xx)
UA (1) UA93365C2 (xx)
WO (1) WO2006095363A2 (xx)
ZA (1) ZA200705729B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009155315A (ja) * 2007-12-26 2009-07-16 Fujiyakuhin Co Ltd 注射剤
WO2013005226A1 (en) * 2011-07-04 2013-01-10 Zota Health Care Ltd A novel combined pharmaceutical composition containing diclofenac and methods of making and using the same
US20140187635A1 (en) 2012-12-28 2014-07-03 Themis Medicare Limited Diclofenac compositions
US20140275261A1 (en) 2013-03-15 2014-09-18 Dr. Reddy's Laboratories, Inc. Diclofenac parenteral compositions
CN103432132B (zh) * 2013-08-31 2015-01-21 西南大学 甲磺酸普立地诺双氯芬酸钠注射液及其制备方法
WO2016170401A1 (en) * 2015-04-20 2016-10-27 Umedica Laboratories Pvt. Ltd Novel injectable composition of diclofenac sodium
US20220280463A1 (en) 2019-09-09 2022-09-08 Ftf Pharma Private Limited Pharmaceutical formulations comprising diclofenac

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0185374A2 (de) * 1984-12-21 1986-06-25 Merckle GmbH Flüssige Diclofenac-Zubereitungen
EP0595766A1 (de) * 1992-10-22 1994-05-04 Ciba-Geigy Ag Parenterale Lösungen für Diclofenacsalze
US5554650A (en) * 1994-07-28 1996-09-10 Southern Research Institute Antiphlogistic, analgesic, antipyretic injection preparation
CH696034A5 (de) * 2001-02-07 2006-11-30 Underberg Kg Flasche mit im Boden ausgebildeten Griffmulden.

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8200488L (sv) 1982-01-29 1983-07-30 Svenska Flaektfabriken Ab Arreteringsanordning, serskilt for forankring av till- och franluftventiler i ventilationskanaler
DE3328401A1 (de) 1983-08-05 1985-02-21 Merckle GmbH, 7902 Blaubeuren Injizierbare loesung zur behandlung von entzuendungen
DE3613799C1 (de) 1986-04-24 1987-09-03 Nattermann A & Cie Verwendung von Glycofurol zum Verfluessigen von Arzneimittelzubereitungen fuer das Abfuellen in Weichgelatinekapseln
AU7880991A (en) 1990-05-10 1991-11-27 Novo Nordisk A/S A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
ZA949182B (en) 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
GB9502695D0 (en) 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition
US5747058A (en) 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
HUP9903249A3 (en) 1996-06-25 2001-04-28 Glaxo Group Ltd Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
US5853263A (en) * 1996-08-15 1998-12-29 Accrued, Inc. System for installing raised road markers
US6846495B2 (en) * 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
IN192711B (xx) 2002-01-22 2004-05-15 Ketan Rajnibhai Patel
CH694034A8 (de) * 2002-12-12 2004-08-31 Mepha Ag Diclofenac-Kalium-Injektionsloesung.
EP1605916A4 (en) * 2003-02-12 2012-02-22 R & P Korea Co Ltd SOLUBENT SOLVENT SYSTEM WITH SOLUBLE PEEL WITH IMPROVED ELUTION RATE
KR100612070B1 (ko) * 2003-02-12 2006-08-11 알앤피코리아주식회사 용출률이 향상된 난용성 약제의 용매 시스템 및 이를 함유한 제약학적 제제
CN1557290A (zh) 2004-01-19 2004-12-29 江苏扬子江药业集团有限公司 复方双氯芬酸钾注射液制剂
ES2287658T3 (es) 2004-03-10 2007-12-16 Shimoda Biotech (Pty) Ltd Composiciones inyectables estables de diclofenac.
CN1279897C (zh) 2004-04-30 2006-10-18 济南百诺医药科技开发有限公司 含有双氯芬酸盐和利多卡因的冻干制剂及其制备方法
ITMI20041245A1 (it) 2004-06-22 2004-09-22 Ibsa Inst Biochimique Sa Composizioni farmaceutiche iniettabnili comprendenti diclofenac sodico e b-ciclodestrina

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0185374A2 (de) * 1984-12-21 1986-06-25 Merckle GmbH Flüssige Diclofenac-Zubereitungen
EP0595766A1 (de) * 1992-10-22 1994-05-04 Ciba-Geigy Ag Parenterale Lösungen für Diclofenacsalze
US5554650A (en) * 1994-07-28 1996-09-10 Southern Research Institute Antiphlogistic, analgesic, antipyretic injection preparation
CH696034A5 (de) * 2001-02-07 2006-11-30 Underberg Kg Flasche mit im Boden ausgebildeten Griffmulden.

Also Published As

Publication number Publication date
AU2009233594A1 (en) 2009-11-19
PT1848419E (pt) 2012-10-31
IL184697A0 (en) 2007-12-03
WO2006095363A2 (en) 2006-09-14
CA2596031C (en) 2013-02-19
US8809393B2 (en) 2014-08-19
AU2006221633A1 (en) 2006-09-14
WO2006095363B1 (en) 2007-02-01
UA93365C2 (ru) 2011-02-10
BRPI0606119A2 (pt) 2009-06-02
WO2006095363A3 (en) 2006-12-14
ES2392097T3 (es) 2012-12-04
ZA200705729B (en) 2008-08-27
US20080153914A1 (en) 2008-06-26
EP1848419A2 (en) 2007-10-31
IL184697A (en) 2014-02-27
KR20070107091A (ko) 2007-11-06
DK1848419T3 (da) 2012-11-05
BRPI0606119B8 (pt) 2021-05-25
CN101123957B (zh) 2010-12-08
KR101226121B1 (ko) 2013-01-25
BRPI0606119B1 (pt) 2019-05-07
EA200701645A1 (ru) 2008-02-28
AP2007004101A0 (en) 2007-08-31
MX2007009312A (es) 2008-03-10
CN101123957A (zh) 2008-02-13
CA2596031A1 (en) 2006-09-14
EA013616B1 (ru) 2010-06-30
EP1848419B1 (en) 2012-07-25
PL1848419T3 (pl) 2012-12-31
JP2008528572A (ja) 2008-07-31
NZ554779A (en) 2011-02-25
AU2006221633B2 (en) 2009-07-30

Similar Documents

Publication Publication Date Title
EP1951248A4 (en) NEW COLORED SOLUTIONS OF INJECTABLE MEDICINAL PRODUCTS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
IL184735A0 (en) Pharmaceutical formulations and methods of use
IL190292A (en) History of pyridopyrimidinone and their pharmaceutical preparations
IL191160A0 (en) Pyridopyrazine derivatives and use thereof
IL193198A0 (en) Long-actine polypeptides and methods of producing and administering same
EP1909780A4 (en) AGAINST TUBERCULOSIS, COMPOSITIONS AND PROCEDURES
EP2054063A4 (en) 4-AMINOCHINAZOLINE DERIVATIVES AND METHOD FOR THEIR USE
PL1861387T3 (pl) Pochodne benzoimidazolu i ich kompozycje farmaceutyczne
EP1968943A4 (en) IMPROVED METHOD FOR THE PRODUCTION OF MONTELUCASTAST AND THE PHARMACEUTICALLY SAFE SALTS
PT1861387E (pt) Derivados de benzimidazol e composições farmacêuticas dos mesmos
GB0516069D0 (en) Pharmaceutical and use thereof
ZA200803283B (en) Pharmaceutical gallium compositions and methods
IL184697A0 (en) Injectable preparations of diclofenic and its pharmaceutically acceptable salts
GB0606234D0 (en) Pharmaceutically acceptable salts and polymorphic forms
SI1828137T1 (sl) 4-cikloalkil-substituirani derivati tetrahidrokinolina in njihova uporaba kot zdravila
EP1883619A4 (en) PROCESS FOR THE PREPARATION OF SUBSTITUTED TETRAFLUOROBENZYLANILINE COMPOUND AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
EP1852432A4 (en) NITROGENIC HETEROCYCLIC COMPOUND AND THEIR MEDICAL USE
IL195493A0 (en) Combination preparations comprising bifeprunox and l-dopa
IL186337A0 (en) Stannsoporfin compositions and administration
EP1803452A4 (en) ESTER DERIVATIVE AND ITS PHARMACEUTICAL USE THEREOF
GB0519891D0 (en) Pharmaceutically acceptable salts and hydrates
IL191892A0 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
IL189827A0 (en) Pharmaceutical dosage forms and compositions comprising lecoztan
EP1865777A4 (en) STANNSOPORFIN COMPOSITIONS AND ADMINISTRATION
EP1944298A4 (en) CHINAZOLINE DERIVATIVE AND PHARMACEUTICALS